Clinical InvestigationInterventional CardiologyClopidogrel prescription filling delays and cardiovascular outcomes in a pharmacy system integrating inpatient and outpatient care: Insights from the Veterans Affairs CART Program
Section snippets
Setting
The VA Clinical Assessment, Reporting, and Tracking (CART) Program is a national clinical quality program that tracks coronary procedures in all VA catheterization laboratories. In contrast to some catheterization laboratory registries, the CART Program mandates reporting of all catheterization laboratory cases, decreasing the likelihood of selection bias in the reported cases. The CART uses a point-of-care software application embedded in the VA electronic health record that allows providers
Results
The analytic cohort consisted of 8,382 patients, 7,775 of whom filled their clopidogrel prescription on the day of discharge and 607 (7.2%) of whom delayed between 1 and 30 days. In patients with a delay in filling clopidogrel prescription, the mean delay time was 14.4 days (SD 11.3 days), and the median delay was 11 days (interquartile range 3-28 days). In univariate analysis, patients who delayed filling their prescription more often presented for PCI in cardiogenic shock (P < .001) and had a
Discussion
In a large, national health care delivery system with an integrated inpatient and outpatient pharmacy service, we found that approximately 1 in 14 patients delayed filling clopidogrel prescriptions after PCI with stent implantation. Moreover, delay in filling a clopidogrel prescription was associated with increased risk of near-term major adverse events after PCI. At the patient level, delay in clopidogrel prescription filling was associated with increased risk of adverse outcomes. If patients
Disclosure
Dr Byrd, investigator: Medtronic clinical trial. Dr Bhatt, advisory board: Medscape Cardiology; board of directors: Boston VA Research Institute and Society of Chest Pain Centers; chair: AHA Get With The Guidelines Science Subcommittee; honoraria: ACC (Editor, Clinical Trials, Cardiosource), Duke Clinical Research Institute (clinical trial steering committees), Slack Publications (Chief Medical Editor, Cardiology Today Intervention), and WebMD (CME steering committees); other: Senior Associate
References (14)
- et al.
Using health information technology-related performance measures and tools to improve chronic care
Jt Comm J Qual Patient Saf
(2009) - et al.
ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non-ST-Elevation Myocardial Infarction) Developed in Collaboration With the American Academy of Family Physicians and American College of Emergency Physicians Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine
J Am Coll Cardiol
(2008) - et al.
A primer and comparative review of major US mortality databases
Ann Epidemiol
(2002) - et al.
Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry
J Am Coll Cardiol
(2010) - et al.
Effect of a prior authorization process on antiplatelet therapy and outcomes in patients prescribed clopidogrel following coronary stenting
Can J Cardiol
(2006) - et al.
Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease
BMC Cardiovasc Disord
(2006) - et al.
Primary medication non-adherence: analysis of 195,930 electronic prescriptions
J Gen Intern Med
(2010)
Cited by (5)
Improving anti-platelet therapy adherence in the Veterans Health Administration: A randomized multi-site hybrid effectiveness-implementation study protocol
2019, Contemporary Clinical TrialsCitation Excerpt :Approximately 1 in 14 patients delayed filling P2Y12 inhibitor at the time of PCI hospital discharge, however, this delay varied by hospital, ranging from 0% to 44% [5]. These findings suggest that an individual site's policies and procedures could potentially affect patients' access to anti-platelet treatment [5]. Other studies have described multiple reasons for non-adherence in patients, both system and patient-related [6–10].
Impact of a pharmacist collaborative drug therapy management protocol on utilization of a discharge prescription program and hospital readmissions
2023, American Journal of Health-System PharmacyMultifaceted Intervention to Improve P2Y12 Inhibitor Adherence After Percutaneous Coronary Intervention: A Stepped Wedge Trial
2022, Journal of the American Heart AssociationSystematic review of the clinical impact of dual antiplatelet therapy discontinuation after acute coronary syndromes
2017, European Heart Journal: Acute Cardiovascular Care